JP2024534032A - ボツリヌス毒素中毒を処置するための方法 - Google Patents

ボツリヌス毒素中毒を処置するための方法 Download PDF

Info

Publication number
JP2024534032A
JP2024534032A JP2024508945A JP2024508945A JP2024534032A JP 2024534032 A JP2024534032 A JP 2024534032A JP 2024508945 A JP2024508945 A JP 2024508945A JP 2024508945 A JP2024508945 A JP 2024508945A JP 2024534032 A JP2024534032 A JP 2024534032A
Authority
JP
Japan
Prior art keywords
subject
diaminopyridine
body weight
pharma
botulism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534032A5 (https=
Inventor
パトリック マクナット，
Original Assignee
カタリスト ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カタリスト ファーマシューティカルズ， インコーポレイテッド filed Critical カタリスト ファーマシューティカルズ， インコーポレイテッド
Publication of JP2024534032A publication Critical patent/JP2024534032A/ja
Publication of JP2024534032A5 publication Critical patent/JP2024534032A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024508945A 2021-08-19 2022-08-11 ボツリヌス毒素中毒を処置するための方法 Pending JP2024534032A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163234970P 2021-08-19 2021-08-19
US63/234,970 2021-08-19
PCT/US2022/074849 WO2023023463A1 (en) 2021-08-19 2022-08-11 Method for treating botulinum toxin poisoning

Publications (2)

Publication Number Publication Date
JP2024534032A true JP2024534032A (ja) 2024-09-18
JP2024534032A5 JP2024534032A5 (https=) 2025-08-06

Family

ID=85239795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508945A Pending JP2024534032A (ja) 2021-08-19 2022-08-11 ボツリヌス毒素中毒を処置するための方法

Country Status (4)

Country Link
US (1) US20230074200A1 (https=)
EP (1) EP4387620A4 (https=)
JP (1) JP2024534032A (https=)
WO (1) WO2023023463A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
US20080118553A1 (en) * 2006-06-12 2008-05-22 Anton Frenkel Tannate salt form of polypeptide mixtures, their preparation and use
WO2014189830A1 (en) * 2013-05-20 2014-11-27 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Calcium channel agonists

Also Published As

Publication number Publication date
EP4387620A1 (en) 2024-06-26
US20230074200A1 (en) 2023-03-09
WO2023023463A1 (en) 2023-02-23
EP4387620A4 (en) 2025-06-25

Similar Documents

Publication Publication Date Title
Barbaro et al. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double‐blind, placebo‐controlled, cross‐over study
AU2022204217B2 (en) Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
JP5289765B2 (ja) 自閉症、強迫神経症、および衝動性の治療のためのメマンチン（ナメンダ）の使用
Fraser et al. Intravesical liposome administration—a novel treatment for hyperactive bladder in the rat
AU2015341458A1 (en) Methods for treatment of cognitive decline
WO2014172341A1 (en) Compositions and methods for the treatment of brain injury
US20210275580A1 (en) Iron carbohydrate complex for treatment of restless leg syndrome (rls)
Sasanami et al. Oral ethanol treatment for ethylene glycol intoxication
IL268930B1 (en) Citrulline for treatment of sickle cell crisis
US9724317B2 (en) Compositions and methods for the treatment of a common cold and symptoms thereof
RU2431496C2 (ru) Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение
JP2024534032A (ja) ボツリヌス毒素中毒を処置するための方法
US20230364030A1 (en) Parenteral treatments involving aminoadamantane derivatives
US20240156856A1 (en) Novel applications of hyaluronic acid for treatment of pain and pruritis
EP1865952A1 (en) Histamine-containing composition for the treatment of allergic diseases
US20140162958A1 (en) Copolymer-1 Composition and Methods of Use
Naveed New application of an old drug proparacaine in curing epilepsy via liposomal hydrogel formulation
WO1999007356A1 (en) Nicotine antagonists for neuropsychiatric disorders
KR20250133576A (ko) 연골 손상 치료용 약물 전달체 및 이를 이용한 연골 손상으로 인한 질병 예방 또는 치료용 약학적 조성물
US8680145B1 (en) Compositions and methods for treatment of fear of medical procedures
KR102118227B1 (ko) 척추 투여용 과포화 아세타미노펜 주사 용액
EA046226B1 (ru) Применение фармацевтической композиции в качестве лекарственного средства для защиты и/или репарации/восстановления гематоэнцефалического барьера
Tamura et al. Clinical Manifestations of Acute Baclofen Toxicity in Adults
Preetha A comparative study of lignocaine and Ondansetron as pretreatment to prevent Pain on injection of propofol
HK40017808A (en) Methods of treating seizure disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250729